These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19829029)

  • 1. Intermediate-risk group in patients with transitional cell carcinoma of the bladder: prediction of high-risk patients in this heterogeneous group.
    Yencilek F; Onal B; Erozenci A; Talat Z; Ataus S
    Urol Int; 2009; 83(3):295-9. PubMed ID: 19829029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of superficial bladder cancer in Victoria: 1990 and 1995.
    Frydenberg M; Millar JL; Toner G; Bolton D; Syme R; Thursfield VJ; Giles GG;
    ANZ J Surg; 2005 May; 75(5):270-4. PubMed ID: 15932435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transitional cell bladder carcinoma in patients younger than 40 years of age].
    Madrid García FJ; Parra Muntaner L; Rivas Escudero JA; Sánchez Sánchez E; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1998 Dec; 51(10):991-4. PubMed ID: 9951121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
    Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
    J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
    Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
    Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence for predicting recurrence-free probability of non-invasive high-grade urothelial bladder cell carcinoma.
    Cai T; Conti G; Nesi G; Lorenzini M; Mondaini N; Bartoletti R
    Oncol Rep; 2007 Oct; 18(4):959-64. PubMed ID: 17786360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy.
    Whitson J; Berry A; Carroll P; Konety B
    BJU Int; 2009 Aug; 104(3):336-9. PubMed ID: 19220253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
    Gupta NP; Sharma N; Kumar R
    Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
    Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
    Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
    Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
    Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
    Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC
    Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.